Literature DB >> 4718678

Differential cell permeability and the basis for selective activity of methotrexate during therapy of the L1210 leukemia.

F M Sirotnak, R C Donsbach.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4718678

Source DB:  PubMed          Journal:  Cancer Res        ISSN： 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  6 in total

Review 1.  Selective uptake and retention of anticancer agents by sensitive cells.

Authors:  D L Hill; J A Montgomery
Journal:  Cancer Chemother Pharmacol       Date:  1980       Impact factor: 3.333

2.  Pharmacokinetics of methotrexate in leukemia cells: effect of dose and mode of injection.

Authors:  J M Weissbrod; R K Jain; F M Sirotnak
Journal:  J Pharmacokinet Biopharm       Date:  1978-12

3.  New folate analogs of the 10-deaza-aminopterin series. Basis for structural design and biochemical and pharmacologic properties.

Authors:  F M Sirotnak; J I DeGraw; D M Moccio; L L Samuels; L J Goutas
Journal:  Cancer Chemother Pharmacol       Date:  1984       Impact factor: 3.333

4.  New folate analogs of the 10-deaza-aminopterin series. Further evidence for markedly increased antitumor efficacy compared with methotrexate in ascitic and solid murine tumor models.

Authors:  F M Sirotnak; J I DeGraw; F A Schmid; L J Goutas; D M Moccio
Journal:  Cancer Chemother Pharmacol       Date:  1984       Impact factor: 3.333

5.  The interaction between fluoropyrimidines and methotrexate, and [4C]-formate incorporation into nucleic acids and protein.

Authors:  D Bowen; E Fölsch; L A Guernsey
Journal:  Cancer Chemother Pharmacol       Date:  1980       Impact factor: 3.333

6.  Methotrexate and the need for continued research.

Authors:  F Rosenfelt
Journal:  Yale J Biol Med       Date:  1975-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.